What this covers

Fyodor Urnov, who coined the term "gene editing," sits down to explain how the field moved from concept to clinical reality in less than a decade. The conversation centers on two distinct editing strategies: first, moving naturally occurring protective variants—like the CCR5 deletion that shields against HIV or hemoglobin variants that cure sickle cell disease—from resistant individuals to patients; second, using CRISPR-Cas9 and related tools to precisely rewrite DNA by exploiting the body's own ancient repair pathways. Urnov explains the mechanics: how Fooling Nature's Repair Machinery through homology-directed repair lets scientists insert edits with astonishing efficiency, and how end joining can create a gene knockout by introducing frameshifts. He grounds the discussion in real cases—Victoria Gray's cure from sickle cell disease, approved cancer immunotherapies, and clinical trials underway for hemophilia and congenital blindness.

The conversation then turns to consequences and boundaries. Urnov distinguishes between somatic edits (in consenting adults) and germline editing (heritable changes), arguing the latter should be criminalized everywhere because no unmet medical need justifies it and no way exists to verify enhancement outcomes that take decades to appear. He confronts the reality that CRISPR-Cas9's technical simplicity makes rogue embryo editing inevitable and already happening, and addresses the reputational damage GMOs suffered—a wound he sees as irreparable. The discussion also covers Genetic vs Epigenetic Editing, including reversible epigenetic edits being developed for radiation protection, and outlines near-term prospects: pain management via the endocannabinoid system, heart-attack prevention through PCSK9 deletion, and why regulatory agencies' refusal to recognize aging as a disease makes longevity trials nearly impossible.

Sharpest takeaway

Urnov argues that precise gene and epigenome editing has rapidly moved from concept to clinical reality—curing diseases like sickle cell by transferring natural protective variants—while germline editing should be banned forever and the easy accessibility of CRISPR makes some rogue 'designer' use inevitable.

  • Gene editing exploits Mother Nature's own DNA-break repair pathways (end joining and homology-directed copy-paste) rather than inventing new biology
  • Therapeutic editing works by moving naturally occurring protective variants (CCR5, hemoglobin, PCSK9) from resistant people to patients
  • CRISPR's low technical barrier means germline editing must be criminalized everywhere, while consenting-adult somatic edits are ethically acceptable

The argument · threads8 threads · 32 claims
0.81

Safe, ethical somatic gene editing can cure or substantially reduce genetic diseases including sickle cell, hemophilia, and HIV infection.

6 pointscentrality 5/5
  • A core therapeutic strategy is moving naturally occurring protective genetic variants from resistant individuals to patients: deleting CCR5 (discovered in San Francisco AIDS-era individuals who stayed HIV-free) protects against HIV, and recreating a natural reduced-globin variant cures sickle cell disease.

    “natural genetic variation or transferring genetic variation naturally from one person to another became a therapeutic modality”

  • Cancer immunotherapy, which emerged in the late 1990s and now includes two approved medicines, works by removing a patient's immune cells, inserting a gene encoding a new molecule that directs those cells to attack the cancer, and returning the reprogrammed cells to the body.

    “you could cause the body's own immune system to attack the cancer... When you take the immune system cells out, you stick a gene that encodes or specifies the production of that new molecule. You put the cells back in and lo and behold, the cells now re-routed or re-programmed.”

  • Within the next five to ten years, gene editing will deliver dramatic advances—more cures for certain cancers via editing the immune system, substantial reduction of the burden of sickle cell disease and hemophilia, non-addictive treatment of chronic pain by editing pain or endocannabinoid genes, and prevention of heart attacks by deleting PCSK9—though prediction beyond ten years is impossible because future technologies are unknowable.

    “There absolutely will be dramatic advances in the treatment of certain forms of cancer using this approach... I am completely convinced that the next five to 10 years, we'll see more cures”

  • In just eight years from Jennifer Doudna's Berkeley discovery of how CRISPR works to a clinical cure, the field moved at extraordinary speed—exemplified by Victoria Gray, who was gene edited about a year prior for sickle cell disease and no longer has the disease.

    “In eight years from when Jennifer Doudna here on the Berkeley campus discovered how CRISPR works, we went in just eight years from the discovery to a cure.”

  • To edit an organ like the eye or liver in a living person, the gene editor is enveloped in an innocuous virus that has been gutted of its own contents and filled with the editor; injecting it into the eye or bloodstream lets it home to and infect the target cells—already done clinically for congenital blindness and hemophilia.

    “Typically, that's done by enveloping the editor in a virus... it's made even more innocuous by gutting it of whatever it had and replacing its insides with a gene editor.”

  • Rare individuals lacking a normal copy of PCSK9 have vanishingly low heart-attack risk yet are otherwise fine, so active efforts—with clinical trials possibly starting as early as 2022—aim to prospectively delete this gene in people at severe cardiovascular risk before they suffer a heart attack.

    “those rare individuals who don't have a normal copy, they seem to be fine, except they don't get heart attacks... their risk for heart attack is just vanishingly low”

0.72

Gene editing works by precisely breaking DNA at a target site and using the body's repair machinery to install desired changes.

4 pointscentrality 5/5
  • Cutting a gene and letting Nature's error-prone end-joining repair gain or lose one or two letters causes a frameshift—because the genetic code is read in three-letter words from a continuous string, everything after the insertion or deletion becomes gibberish, which effectively knocks out the gene.

    “if you gain or lose just a letter or two, everything after the mistake is gibberish. Scientists call this a frame shift, which means an inability to correctly interpret where the genetic text starts and ends its words.”

  • Gene editing is precise genetic engineering done to DNA exactly as a word processor edits text—opening the genetic 'document,' selecting a spot, and making a desired change—which is why the term was coined by explicit analogy to word processing.

    “The reason that we coined the term gene editing as an umbrella phrase to describe ways of precise genetic engineering is by explicit analogy to word processing.”

  • You can edit a gene precisely by breaking the chromosome at a target site and supplying a lab-made DNA template nearly identical to the broken region but with a deliberate one-letter change; Nature's homology-directed repair mistakes the template for the chromosome's identical 'sister' and copy-pastes the change in—working astonishingly well, with roughly half of human blood stem cells acquiring the edit.

    “When you break a chromosome in a precise location and then put inside the cell a piece of DNA that is identical to the broken stretch, but you make a tiny change, you literally change one letter, mother nature will not notice and will copy-paste that change into the chromosome.”

  • The molecular machinery that heals DNA breaks is one of the oldest known, so conserved that biologists studying budding yeast and human cells use the exact same gene nomenclature—a striking marker of how anciently evolved and preserved the system is.

    “their machinery for repairing that kind of damage is so similar that biologists who study that repair machinery in human cells use the exact same nomenclature for the bits and pieces of it as the biologists who study yeast”

0.72

Germline editing that passes changes to future generations should never be allowed because there is no unmet medical need and remaining motives are unjustifiable enhancement.

4 pointscentrality 5/5
  • Germline editing—genetic engineering that passes to future generations—should never be allowed under any circumstances: there is no unmet medical need since the burden of genetic disease can be addressed by safe, ethical somatic means, and the only remaining motive is human enhancement, which is unjustifiable because we have no mechanical way to verify enhancement outcomes that take decades to manifest.

    “Germline editing of human beings should never be allowed under any circumstances. Period, end of paragraph.”

  • Because CRISPR is technologically straightforward—requiring modest know-how and purchasable materials, unlike nuclear reactors—rogue enhancement of human embryos is already happening and cannot be fully prevented; the only response is to make embryo and baby editing a crime everywhere so anyone caught goes to jail, which can drive prevalence low but not to zero.

    “I am absolutely convinced that there are laboratories right now, they're underground... who are enhancing embryos for people with too much money and not enough understanding of the science and not enough ethics. That's happening, and I don't think there's any way to prevent that from happening.”

  • Jiankui He committed two crimes: he irreversibly stained the field of disease-focused genetic engineering with the imprint of designer babies, and—more deeply—he demonstrated to the world's rogues that human embryo editing can actually be done.

    “the first crime is he irreversibly stained my field of genetic engineering to treat disease with a imprint of designer baby... the other thing that's even a deeper crime is he showed to the rogues of the world that this can be done”

  • The reputational damage done to genetically modified organisms by publicity is, in Urnov's view, never going to be repaired—GMOs are actually safe, but the public will never accept that, which is partly why the distinct term 'gene editing' was coined.

    “I think the damage that has been done by the publicity around GMOs I think is never gonna be repaired. I think we're just stuck with us. They're actually safe, but the public will never accept that fact, we just have to move on.”

0.58

Gene editing enables non-addictive pain treatment and epigenetic editing can produce temporary, reversible changes suited to specific medical scenarios.

4 pointscentrality 4/5
  • Because certain people naturally lack genes required to transmit pain (and others naturally have an over-active endocannabinoid system), gene editing those systems could create a non-opioid, non-addictive treatment for chronic and breakthrough cancer pain—potentially entering the clinic in three to five years.

    “there is a gene, it's kind of astonishing, there is now we know two genes and if you get rid of it, people feel no pain”

  • Urnov and colleagues are working on a DARPA-funded project to use CRISPR to create a temporary epigenetic edit—lasting only weeks—to protect the bone marrow and gut of war fighters, first responders, and radiation-oncology patients from radiation poisoning, a scenario where a reversible epigenetic edit is preferable to a permanent genetic one.

    “working on a project funded by DARPA to create such an epigenetic change using CRISPR, in America's war fighters, to protect them from radiation damage”

  • Epigenetic editing changes what genes do—turning them on or off and tuning timing—without changing the DNA sequence; because epigenetic marks are like molecular makeup rather than permanent diamonds, the edit's duration can be dialed in to last only weeks or months and then fade, unlike a permanent genetic change.

    “Epigenetics is a change in the way an organism looks without a change in their DNA... the genetic code specifies what the genes say; epigenetics specify whether they say it and how they say it and when.”

  • A permanent edit boosting damage resistance is undesirable because the body's damage-response system has benefits—an overly damaged cell normally dies a natural death rather than surviving and potentially turning cancerous—so for war fighters the Department of Defense wisely chose a temporary, reversible edit to return them to their pre-military genetic state.

    “That system for protecting us against damage has its benefits, you know if a cell is too damaged, then you know, it might die a normal death rather than survive and potentially acquire a cancerous change.”

0.50

Somatic gene enhancement of consenting adults is acceptable under regulatory review and informed consent, analogous to approved cosmetic procedures.

2 pointscentrality 4/5
  • Designer grown-ups are inevitable: just as statins were first approved for rare heart disease and only later became widely used preventatives once proven safe, gene editing will follow the same path—once safe and effective for treating disease, applications like editing the androgen receptor gene to cure baldness (e.g. CRISPR in shampoo) will emerge into an enormously lucrative market.

    “There will be designer grown-ups, for sure. There's no question in my mind. And the only thing that needs to happen for that is a few years need to pass for the FDA to grow comfortable with a safety and efficacy record of gene editing for treating disease.”

  • Genetic enhancement of consenting adults via somatic editing is acceptable so long as the procedure passes regulatory review and the person consents with eyes open—analogous to FDA-approved Botox (a dangerous toxin) for wrinkles or getting a tattoo—because the key issue is free-will consent and people must understand a gene edit is permanent and they will live with its consequences.

    “As long as consenting adults apply to themselves things that have passed regulatory review by the FDA, by Health Canada, by the EMA, I'm totally fine, but the key issue here is consent.”

0.44

Gene-edited crops and viral-vector delivery systems are already clinically deployed, while foundational science enables advances people often fail to recognize.

7 pointscentrality 2/5
  • Because only about 5% of human DNA actually codes for genes, the error-prone end-joining repair pathway occasionally losing a letter or two is tolerable—most breaks occur in non-coding regions, so a roughly 1-in-20 error rate is acceptable to Nature.

    “Only 5% of human DNA is actually coding for genes. And that means that only 5% of the breaks will happen in areas of the genome that make proteins that make you and I. And thus, you know what? One in 20 is okay.”

  • The first gene-edited crop marketed in the United States—distinct from old-school transgenic GMOs that already make up over 90% of US corn, cotton, and soybean—will be waxy corn produced via a gene knockout (not insertion) for starch production.

    “the first genetically engineered gene edited crop that was marketed in the United States... it will be waxy corn, it will be used for the production of starch... it will be actually such a gene knockout”

  • The human genome is 6.6 billion letters long—so long that reading it one letter per second would take a century—and most living systems strongly resist any change to their DNA because it is the storage document of who they are.

    “if you read the genetic code one letter at a time... One second at a time, it'll take you a century to read the entire human genome”

  • Most people don't realize the GPS on their phones works because of Einstein's theory of relativity, illustrating how the real-world relevance and resonance of foundational science is often unpredictable and invisible to users.

    “I think most people don't know that the GPS on their phones works on Einstein's Theory of Relativity”

  • Urnov is excited about genetically vaccinating humans against viral infections—starting in the developing world to protect people at risk for HIV where medication access is limited—and foresees gene or epigene edits deployed like an annual vaccine to protect against future coronaviruses, subject to regulatory review and the highest ethical standards of informed consent.

    “I'm actually excited about the prospect of genetic engineering of humans to genetically vaccinate them for viral infections.”

  • The fundamental mechanics of diagnosing whether someone has the coronavirus rely on tried-and-true, decades-old molecular biology techniques like RNA extraction and qPCR that every molecular and cell biology PhD learns in their first month, even though most people never connect testing to these foundational tools.

    “the fundamental mechanics of how one diagnosis an individual to have the virus rely on, I guess, decades-old techniques, which are tried and true”

  • Spina bifida is an epigenetic error rather than a genetic one: folate is a vitamin supplying an essential biochemical piece to the epigenetic machinery during neural tube development, so a pregnant or pre-pregnant woman supplementing folate substantially reduces—though does not fully eliminate—the risk of delivering a child with a neural tube defect.

    “that's not a genetic error, it's an epigenetic error... if mom doesn't give him enough folate in her diet, then the epigenome... will be wrong and that babies are at risk for getting spina bifida”

0.40

Real-world medical progress requires convergence of multiple technologies and behaviors, not a single breakthrough, making outcomes depend on broader context.

3 pointscentrality 3/5
  • Real-world solutions require multiple sub-units from different fields converging, not a single technology—exemplified by Neil Armstrong's moon space suit being sewn by Playtex seamstresses rather than built by the rocket contractor—so the impact of CRISPR on the pandemic depends on many technologies and behaviors, including people wearing masks.

    “the space suit that Neil Armstrong walked the moon in was not made by one giant contractor, it was made by Playtex. Seamstresses at Playtex sewed the space suit.”

  • Medicine has crossed two irreversible thresholds: the age of the genetically engineered human—with approved medicines for cancer and genetic disease that engineer people, reducing the public-health burden of genetic, infectious, and cancer diseases in the developed world over coming decades—and an age where we not only read but understand human DNA and translate those discoveries into therapeutics far faster than ever, dropping from about 15 years to two.

    “we have entered the age of the genetically engineered human. That is irreversible, there are now approved medicines for cancer and for genetic disease where people get genetically engineered.”

  • Quoting Sydney Brenner, progress in science comes from new technologies, new discoveries, and new ideas—probably in that order—and gene editing exemplifies that we are in a technology-driven space, much as the personal computer's trajectory from the early 1980s was driven by miniaturization and produced unanticipatable consequences.

    “Progress in science comes from new technologies and new discoveries and new ideas probably in that order”

0.22

Regulatory and practical barriers make gene-editing trials for aging extremely difficult despite known longevity-associated variants.

2 pointscentrality 2/5
  • Rather than curing aging directly, the realistic path is engineering molecular machines that crank up the body's defenses against damage in specific organs—a liver machine aiding detoxification, a kidney machine protecting against chronic kidney disease, or a heart machine enabling faster healing after a heart attack—since all the conceptual pieces already exist and just need assembling, like building a habitat on Mars.

    “the way this is actually gonna proceed is we need molecular machines that crank up the body's defenses against damage, and that's imaginable. That's, in fact, not science fiction.”

  • Regulatory agencies in the US, Europe, Australia, and Canada do not recognize aging as a disease, and you cannot run a clinical trial for a non-existent disease; combined with the impracticality of waiting decades to measure lifespan, this makes gene-editing trials for longevity extremely hard despite known longevity-associated variants like IGF.

    “Aging is not a disease. The Food and Drug Administration and the European Medicines Agency and the Therapeutics Goods Administration... do not recognize aging as a disease... you cannot, by definition, begin a clinical trial for a disease that doesn't exist.”